Otsuka Pharmaceutical Co., Ltd. et al v. Zenara Pharma Private Ltd. et al
| Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S |
| Zenara Pharma Private Ltd. and Biophore India Pharmaceuticals Private Ltd. |
| 1:2022cv01269 |
| September 27, 2022 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 21, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 Report to the Commissioner of Patents and Trademarks. (ntl) |
| CASE CLOSED (See D.I. 593 in lead case no. 19cv1938-LPS) Associated Cases: 1:20-cv-01599-LPS, 1:22-cv-01269-LPS (ntl) |
SO ORDERED, re (588 in 1:19-cv-01938-LPS, 9 in 1:22-cv-01269-LPS) STIPULATED ORDER Seeking Consolidation of Actions filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 10/20/22. Associated Cases: 1:19-cv-01938-LPS, 1:22-cv-01269-LPS (ntl)
|
| Case associated with lead case: Create association to 1:19-cv-01938-LPS. (ntl) |
| Filing 9 STIPULATION Seeking Consolidation of Actions, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) |
| Filing 8 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biophore India Pharmaceuticals Private Ltd. for Zenara Pharma Private Ltd. filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth) |
| Filing 7 ANSWER to #1 Complaint, by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth) |
| Case Reassigned to Judge Leonard P. Stark of the United States Court of Appeals for the Federal Circuit (due to prior related cases). Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H Lundbeck A/S. (apk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (apk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE,48,059 ;8,349,840 ;8,618,109 ;9,839,637 ;10,307,419. (apk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/19/2022. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 1/10/2023. (apk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd. ( Filing fee $ 402, receipt number ADEDC-3969147.) - filed by Otsuka Pharmaceutical Co., Ltd., H Lundbeck A/S. (Attachments: #1 Exhibit A-G, #2 Civil Cover Sheet)(apk) |
| No Summons Issued. (apk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
